How can longitudinal studies and multi-omics approaches help unravel these complex relationships?

Mar 23, 2021 ... Discordance analysis demonstrates that apoB is a more accurate marker of all-cause mortality risk in statin-treated patients than LDL ... Feb 27, 2025 ... The highest event ratio was observed in patients with high NHHR (34.7%), followed by medium NHHR (29.4%) and low NHHR (27.1%). This ... Background and aims: The UKPDS Risk Engine is a diabetes-specific coronary heart disease (CHD) risk calculator for use in patients without known CHD. Aug 28, 2023 ... Non-high-density lipoprotein cholesterol (non-HDL-C), calculated as total cholesterol (TC) minus HDL-C, has emerged as a potentially superior ... cholesterol and non-HDL cholesterol levels (HDL cholesterol. ⬎ 40 mg/dl). As expected, the triglyceride concentration in- creased proportionally to the ... Mar 14, 2025 ... Total cholesterol. This is sometimes written as 'serum cholesterol' or 'TC' and refers to your overall level of cholesterol. · Non-HDL ... ApoB, non-HDL-C, and LDL-C may be potential biomarkers in RAO patients. Low ApoA1 is an independent risk factor for the development of RVO. Non–HDL-C provides an estimate of lipid-associated risk and is a secondary treatment target after myocardial infarction (MI). Sep 1, 2008 ... Treating elevated cholesterol, especially elevated low-density lipoprotein cholesterol (LDL-C), can slow and perhaps halt the progression of atherosclerosis. Non-HDL cholesterol levels elevated above 3 millimoles per litre (mmol/L) can be a cause for concern. Guidelines for target cholesterol levels vary based on ...